IPC Launches Seven Nitrosamine Impurities Reference Standards

|

IPC Launches Seven Nitrosamine Impurities Reference Standards

Science & Technology
IPC Launches Seven Nitrosamine Impurities Reference Standards

The Indian Pharmacopoeia Commission (IPC) launches seven Indian Pharmacopoeia Nitrosamine Impurities Reference Standards during its first-ever interactive meeting with the Central Drugs Laboratory (CDL) and Central Cosmetics Laboratory (CCL) in Kolkata. The launch marks the first time IPC introduces reference standards specifically for nitrosamine impurities, under the theme “IP 2026: Perspectives, Suggestions & Way Forward” to align national drug testing protocols, laboratory capabilities, and regulatory standards.

Nitrosamine Impurities Reference Standards:

Dimension Key Details
Therapeutic relevance The reference standards are vital for detecting and controlling chemical impurities in formulations for chronic diseases like hypertension, diabetes, gastric disorders, and tuberculosis.
Analytical impact The reference standards enhance India’s capacity for accurate detection, quantification, method validation, and quality assurance, facilitating alignment with global pharmacopoeial standards.
Nitrosamine impurities: nature Nitrosamine impurities comprise chemical compounds identified as genotoxic and carcinogenic.
Nitrosamine impurities: formation pathways Nitrosamine impurities can unintentionally form during active pharmaceutical ingredient (API) synthesis, storage, packaging, or via contamination from raw materials.
Did you find this informative?

Attempt Possible Qs

Q 1 / 2

With reference to the launch of Nitrosamine Impurities Reference Standards, consider the following statements:

1. It marked the first time the IPC introduced reference standards specifically for nitrosamine impurities.
2. The initiative was framed to align national drug testing protocols, laboratory capabilities, and regulatory standards.

Which of the statements given above are correct?